Riboscience — COVID-19 Drug Research

Grant investigators: Chris Somerville and Heather Youngs

This page was reviewed but not written by the grant investigators. Riboscience staff also reviewed this page prior to publication.

Open Philanthropy recommended an investment of $210,000 in Riboscience to support work to test a new drug candidate against COVID-19.

This falls within our work on scientific research, specifically within our interest in advancing science supporting biosecurity and pandemic preparedness.